
Pharmacoeconomic analysis of using biological agents for uncontrolled moderate-to-severe atopic asthma in the Russian Federation
Author(s) -
S. К. Zyryanov,
I. N. Diyakov,
С. Н. Авдеев
Publication year - 2020
Publication title -
farmakoèkonomika
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.177
H-Index - 3
eISSN - 2070-4933
pISSN - 2070-4909
DOI - 10.17749/2070-4909.2019.12.4.268-278
Subject(s) - mepolizumab , omalizumab , medicine , eosinophilia , asthma , pediatrics , immunology , eosinophil , immunoglobulin e , antibody